Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response

  1. Weaver, Z.
  2. Difilippantonio, S.
  3. Carretero, J.
  4. Martin, P.L.
  5. El Meskini, R.
  6. Iacovelli, A.J.
  7. Gumprecht, M.
  8. Kulaga, A.
  9. Guerin, T.
  10. Schlomer, J.
  11. Baran, M.
  12. Kozlov, S.
  13. McCann, T.
  14. Mena, S.
  15. Al-Shahrour, F.
  16. Alexander, D.
  17. Wong, K.-K.
  18. Van Dyke, T.
Revue:
Cancer Research

ISSN: 0008-5472,  1538-7445

Année de publication: 2012

Volumen: 72

Número: 22

Pages: 5921-5933

Type: Article

DOI: 10.1158/0008-5472.CAN-12-0736 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus